FineHeart is a French medical device company focused on creating innovative technologies in the cardiovascular field. The patented FineHeart invention, the I.C.O.M.S. (Implantable Cardiac Output Management System), is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility. It is a game changing therapy for long term circulatory assistance in severe heart failure patients. FineHeart was founded by a team of internationally renowned cardiac surgeons and cardiologists, led by Dr. Stephane Garrigue (ICOMS FLOWMAKER® inventor) and Dr. Philippe Ritter (co-inventor of cardiac resynchronization therapy) and of managers with specific expertise in the medical device industry, led by Arnaud Mascarell (CEO of FineHeart).



A multidisciplinary team of experts in the fight against Severe Heart Failure.

These co-founders adopted a vision of making a miniaturized, fully implantable, pulsatile circulatory support system that would overcome many of the challenges associated with left ventricular assist devices (LVADs) currently on the market.

The overreaching goal is to restore normal cardiac output and allow heart failure patients to return to a normal quality of life.

FineHeart is based in Bordeaux, within Coeur Bersol. Supported by Bordeaux Metropole and the city of Pessac, this new center of excellence is part of the Bordeaux Inno Campus operation.